Hospital in Barcelona investigates CMR based prediction of ventricular tachycardia events in healed myocardial infarction

Photo by Robina Weermeijer

Centro Medico Teknon with collaboration Antonio Berruezo (MD, PhD, Centro Medico Teknon) is commencing recruitment for the clinical trial of CMR based prediction of ventricular tachycardia events in healed myocardial infarction (DEVELOP-VT) (DEVELOP-VT).

All patients will undergo a cardiac magnetic resonance test to calculate their border zone channel (BZC) mass.

The clinical trial started on August 1, 2020.

The indicators for inclusion are:

  • age > 18 years;
  • chronic (> 3 months after the index coronary event), stable ischemic heart disease, irrespectively of the LVEF;
  • life expectancy of > 1 year with a good functional status.

Among the criteria that do not allow participation, the following are indicated:

  • age < 18 years;
  • pregnancy;
  • life expectancy of < 1 year, or bad functional status (NYHA IV functional class);
  • other concomitant structural heart diseases (e.g. congenital, non-ischemic, etc.);
  • previously documented sustained ventricular arrhythmias;
  • impossibility or contraindications to undergo a contrast-enhanced CMR study;
  • concomitant investigation treatments;
  • medical, geographical and social factors that make study participation impractical, and inability to give written informed consent. Patient's refusal to participate in the study.

The contact is Antonio Berruezo, MD, PhD (Barcelona, Spain, 08022).

For more details please follow the link:

https://ichgcp.net/clinical-trials-registry/NCT04599439

Clinical Research News

Upcoming Clinical Trials